CervoMed Competitors and Similar CompaniesClear all
CervoMed's competitors and similar companies include MOMA Therapeutics, Vedanta Biosciences, Alzheon and Therapeutic Solutions International.
 CervoMed CervoMed (formerly known as Diffusion Pharmaceuticals) is a drug-discovery and development company. |  Vedanta Biosciences Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. |  Alzheon Alzheon is a company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders. |  Therapeutic Solutions International Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases. | ||
Founding Date | Founding Date 2001 | Founding Date 2020 | Founding Date 2010 | Founding Date 2013 | Founding Date 2007 |
Type | Type Public | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Charlottesville, US HQ | Locations Cambridge, US HQ Boston, US | Locations Cambridge, US HQ | Locations Framingham, US HQ | Locations Oceanside, US HQ |
Employees | Employees 10 | Employees 67 | Employees 1381% increase | Employees 3310% increase | Employees 357% decrease |
Valuation ($) | Valuation ($) 111.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $99k (FY, 2023) |
Net income | Net income ($27m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($5.5m) (FY, 2017) | Net income ($2.2m) (FY, 2023) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 150m (about 4 years ago) | Latest funding round $ 68m (almost 5 years ago) | Latest funding round $ 15.8m (almost 9 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 236m | Total funding raised $ 185.5m | Total funding raised $ 37.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
MOMA Therapeutics
HQ
Cambridge, US
Employees
67
MOMA Therapeutics is a biotechnology company.
View companyVedanta Biosciences
HQ
Cambridge, US
Employees
138↑ 1% increase
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
View companyAlzheon
HQ
Framingham, US
Employees
33↑ 10% increase
Alzheon is a company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
View companyTherapeutic Solutions International
HQ
Oceanside, US
Employees
3
Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases.
View company